희소 바이오마커 검체 수집 및 안정화 시장 : 바이오마커별, 용도별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

REPORT HIGHLIGHT

Rare Biomarkers Specimen Collection and Stabilization Market size was valued at USD 36,908.32 Million in 2023, expanding at a CAGR of 13.90% from 2024 to 2032.

Rare biomarkers specimen collection and stabilization refers to the process of obtaining biological samples such as blood, urine, tissue, etc. that contain rare or low-abundance biomolecules, which are substances indicative of biological processes or conditions. These biomarkers may be present in very small quantities in the body and can provide critical information about disease states, treatment responses, or physiological changes.

Rare Biomarkers Specimen Collection and Stabilization Market- Market Dynamics

Rising number of drug development & clinical trials and biomedical research are expected to propel market demand

Biomarkers are increasingly used as endpoints in clinical trials to assess drug efficacy and safety. Proper collection and stabilization of rare biomarkers are critical to ensuring the reliability and reproducibility of trial results. Moreover, innovations in sample handling technologies, such as improved stabilizing agents, storage conditions, and transport systems, enhance the reliability and efficiency of rare biomarker collection and stabilization processes. Thus, high demand from clinical trials & advancement in technology is expected to foster market growth.

Technological developments in biotechnology and molecular biology have increased our capacity to find and examine uncommon biomarkers. This emphasizes the necessity for trustworthy techniques for stabilizing and collecting specimens while maintaining the integrity of the biomarker which is contributing to market growth. Treatments are becoming more individualized considering patient genetic, environmental, and biomarker profiles known as personalized medicine. To pinpoint patient-specific traits that affect therapy efficacy and outcomes, rare biomarkers are essential. There is a growing emphasis on cost-effective healthcare solutions. Biomarker-based diagnostics can potentially reduce overall healthcare costs by enabling early disease detection and targeted therapies.

Rare Biomarkers Specimen Collection and Stabilization Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 13.90% over the forecast period (2024-2032)

Based on Biomarker segmentation, circulating cell-free DNA (ccfDNA) segment was predicted to show maximum market share in the year 2023, owing to its high demand in cancer treatment.

Based on Application segmentation, diagnostics segment was the leading application in 2023, due to increased need for chronic disorder care.

Based on End User segmentation, research laboratories segment was the leading End User in 2023, owing to high focus on drug development & novel research.

On the basis of region, North America was the leading revenue generator in 2023, owing to government support & FDA approvals.

Rare Biomarkers Specimen Collection and Stabilization Market- Segmentation Analysis:

The Global Rare Biomarkers Specimen Collection and Stabilization Market is segmented on the basis of Biomarker, Application, End User, and Region.

The market is divided into three categories based on Biomarker: circular cell free DNA, circulating tumor cells, and exosomes. The circular cell free DNA segment dominates the market. High prevalence of blood cancer is primarily boosting segment growth.

The market is divided into five categories based on Application: diagnostics, transcriptomics, pharmacogenomics, cardiovascular diseases, and others. The diagnostics segment dominates the market. The increasing need for treatment of non-invasive cancer and clinical use is accelerating market growth.

The market is divided into three categories based on End User: research laboratories, hospital & clinics, and others. The research laboratories segment dominates the market and is expected to maintain its high dominance during the forecast period. The increasing encouragement from government & FDA approvals in DNA & RNA drug development are boosting market growth.

Rare Biomarkers Specimen Collection and Stabilization Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America, mainly the United States, is a mature market for advanced biomedical research and diagnostics. Several factors like the presence of leading academic institutions, research centers, and biotechnology companies drive demand for advanced specimen collection and stabilization technologies. In addition, significant healthcare spending and insurance coverage facilitate adoption of advanced diagnostic technologies.

Rare Biomarkers Specimen Collection and Stabilization Market- Competitive Landscape:

The competitive landscape of the rare biomarkers specimen collection and stabilization market is shaped by technological advancements, dominated by major players. some of the leading companies in the market such as Thermo Fisher Scientific, QIAGEN, BD Biosciences, Merck KGaA, etc., dominate market share due to their extensive product offerings and global presence. These companies are investing in research and development to innovate new specimen collection devices and stabilization methods that improve biomarker preservation and reliability.

Recent Developments:

In March 2023, nRichDX partnered with OraSure Technologies, Inc., to market their products for scientists working on liquid biopsy applications.

In May 2023, LabCorp launched LabCorp Plasma Focus, a liquid biopsy test which enables tailored therapy selection for people with advanced or metastatic solid cancers.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION AND STABILIZATION MARKET KEY PLAYERS

• Thermo Fisher Scientific
• QIAGEN
• BD Biosciences
• Merck KGaA
• Bio-Rad Laboratories
• Bio-Techne Corporation
• GE Healthcare Life Sciences
• Agilent Technologies
• Roche Diagnostics
• LabCorp
• Promega Corporation
• Illumina, Inc.
• Danaher Corporation
• PerkinElmer, Inc.
• Eppendorf AG
• Lonza Group
• Others

GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION AND STABILIZATION MARKET, BY BIOMARKER- MARKET ANALYSIS, 2019-2032

• Circular Cell Free DNA
• Circulating tumor cells
• Exosomes

GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION AND STABILIZATION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

• Diagnostics
• Transcriptomics
• Pharmacogenomics
• Cardiovascular diseases
• Others

GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION AND STABILIZATION MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

• Research laboratories
• Hospital & clinics
• Others

GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION AND STABILIZATION MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Rare Biomarkers Specimen Collection and Stabilization Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Rare Biomarkers Specimen Collection and Stabilization Market Snippet by Biomarker
  • 2.1.2. Rare Biomarkers Specimen Collection and Stabilization Market Snippet by Application
  • 2.1.3. Rare Biomarkers Specimen Collection and Stabilization Market Snippet by End User
  • 2.1.4. Rare Biomarkers Specimen Collection and Stabilization Market Snippet by Country
  • 2.1.5. Rare Biomarkers Specimen Collection and Stabilization Market Snippet by Region
• 2.2. Competitive Insights

3. Rare Biomarkers Specimen Collection and Stabilization Key Market Trends

• 3.1. Rare Biomarkers Specimen Collection and Stabilization Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Rare Biomarkers Specimen Collection and Stabilization Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Rare Biomarkers Specimen Collection and Stabilization Market Opportunities
• 3.4. Rare Biomarkers Specimen Collection and Stabilization Market Future Trends

4. Rare Biomarkers Specimen Collection and Stabilization Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Rare Biomarkers Specimen Collection and Stabilization Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Rare Biomarkers Specimen Collection and Stabilization Market Landscape

• 6.1. Rare Biomarkers Specimen Collection and Stabilization Market Share Analysis, 2023
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Rare Biomarkers Specimen Collection and Stabilization Market - By Biomarker

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Biomarker, 2024 & 2032 (%)
  • 7.1.2. Circular Cell Free DNA
  • 7.1.3. Circulating tumor cells
  • 7.1.4. Exosomes

8. Rare Biomarkers Specimen Collection and Stabilization Market - By Application

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
  • 8.1.2. Diagnostics
  • 8.1.3. Transcriptomics
  • 8.1.4. Pharmacogenomics
  • 8.1.5. Cardiovascular diseases
  • 8.1.6. Others

9. Rare Biomarkers Specimen Collection and Stabilization Market - By End User

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
  • 9.1.2. Research laboratories
  • 9.1.3. Hospital & clinics
  • 9.1.4. Others

10. Rare Biomarkers Specimen Collection and Stabilization Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. Rare Biomarkers Specimen Collection and Stabilization Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.2.4. North America Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
  • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.2.6. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.2.7.3. U.S. Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.2.8.3. Canada Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.8.5. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. Rare Biomarkers Specimen Collection and Stabilization Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.3.4. Europe Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
  • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.3.6. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.7.3. Germany Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.7.5. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3.8. Italy
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.8.3. Italy Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.8.5. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3.9. United Kingdom
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.9.3. United Kingdom Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3.10. France
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.10.3. France Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.10.5. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3.11. Russia
    • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.11.2. Russia Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.11.4. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3.12. Netherlands
    • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.12.2. Netherlands Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3.13. Sweden
    • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.13.2. Sweden Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3.14. Poland
    • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.14.2. Poland Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.14.4. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3.15. Rest of Europe
    • 10.3.15.1. Overview
    • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. Rare Biomarkers Specimen Collection and Stabilization Key Manufacturers in Asia Pacific
  • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.4.4. Asia Pacific Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
  • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4.7. India
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.7.3. India Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.7.5. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4.8. China
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.8.3. China Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.8.5. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4.9. Japan
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.9.3. Japan Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.9.5. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4.10. South Korea
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.10.3. South Korea Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.11.3. Australia Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.11.5. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4.12. Thailand
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.12.3. Thailand Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4.13. Indonesia
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.13.3. Indonesia Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.14.3. Philippines Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4.15. Rest of APAC
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.15.3. Rest of APAC Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
• 10.5. Latin America
  • 10.5.1. Overview
  • 10.5.2. Rare Biomarkers Specimen Collection and Stabilization Key Manufacturers in Latin America
  • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.5.4. Latin America Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
  • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.5.6. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.7.3. Brazil Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.8.3. Mexico Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.9.3. Argentina Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.10.3. Colombia Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
• 10.6. Middle East and Africa
  • 10.6.1. Overview
  • 10.6.2. Rare Biomarkers Specimen Collection and Stabilization Key Manufacturers in Middle East and Africa
  • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.6.4. Middle East and Africa Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
  • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6.8. United Arab Emirates
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.9.3. Israel Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.9.5. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.10.3. Turkey Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.11.3. Algeria Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.12.3. Egypt Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6.13. Rest of MEA
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.13.3. Rest of MEA Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Rare Biomarkers Specimen Collection and Stabilization Industry

• 11.1. Competitive Dashboard
• 11.2. Company Profiles
  • 11.2.1. Thermo Fisher Scientific
  • 11.2.2. QIAGEN
  • 11.2.3. BD Biosciences
  • 11.2.4. Merck KGaA
  • 11.2.5. Bio-Rad Laboratories
  • 11.2.6. Bio-Techne Corporation
  • 11.2.7. GE Healthcare Life Sciences
  • 11.2.8. Agilent Technologies
  • 11.2.9. Roche Diagnostics
  • 11.2.10. LabCorp
  • 11.2.11. Promega Corporation
  • 11.2.12. Illumina, Inc.
  • 11.2.13. Danaher Corporation
  • 11.2.14. PerkinElmer, Inc.
  • 11.2.15. Eppendorf AG
  • 11.2.16. Lonza Group
  • 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us